Benzinga | Aug 10, 2020 07:49AM EDT

Momenta Pharmaceuticals Q2 EPS $(0.48) Misses $(0.39) Estimate, Sales $6.61M Beat $5.56M Estimate

Momenta Pharmaceuticals (NASDAQ:MNTA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.39) by 23.08 percent. This is a 58.62 percent increase over losses of $(1.16) per share from the same period last year. The company reported quarterly sales of $6.61 million which beat the analyst consensus estimate of $5.56 million by 18.88 percent. This is a 27.56 percent increase over sales of $5.18 million the same period last year.